Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,784 | -12,318 | -17,068 | -8,149 | -1,195 |
| Depreciation Amortization | 20 | 43 | 63 | 201 | 346 |
| Accounts receivable | N/A | N/A | 14 | -480 | -438 |
| Accounts payable and accrued liabilities | 854 | -253 | 7 | 153 | -196 |
| Other Working Capital | 1,846 | 1,520 | -2,558 | 46 | -759 |
| Other Operating Activity | 985 | 3,289 | 10,626 | 5,354 | 1,097 |
| Operating Cash Flow | $-16,079 | $-7,719 | $-8,916 | $-2,875 | $-1,145 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -77 | N/A |
| PPE Investments | -48 | -36 | -10 | 2 | 65 |
| Investing Cash Flow | $-48 | $-36 | $-10 | $-75 | $65 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,672 | 13,457 | 12,882 | 6,979 | 1,129 |
| Other Financing Activity | -1,645 | -1,031 | -680 | 0 | -115 |
| Financing Cash Flow | $19,027 | $12,426 | $12,202 | $6,979 | $1,014 |
| Beginning Cash Position | 14,625 | 9,954 | 6,678 | 2,649 | 2,715 |
| End Cash Position | 17,525 | 14,625 | 9,954 | 6,678 | 2,649 |
| Net Cash Flow | $2,900 | $4,671 | $3,276 | $4,029 | $-66 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,079 | -7,719 | -8,916 | -2,875 | -1,145 |
| Capital Expenditure | -48 | -36 | -10 | 0 | -12 |
| Free Cash Flow | -16,127 | -7,755 | -8,926 | -2,875 | -1,157 |